Disopyramide phosphate and Ventricular tachycardia - a phase IV clinical study of FDA data

Summary:

Ventricular tachycardia is reported as a side effect among people who take Disopyramide phosphate (disopyramide phosphate), especially for people who are female, 60+ old, also take Furosemide, and have Bronchiolitis.

The phase IV clinical study analyzes which people have Ventricular tachycardia when taking Disopyramide phosphate. It is created by eHealthMe based on reports of 470 people who have side effects when taking Disopyramide phosphate from the FDA, and is updated regularly.

What is Disopyramide phosphate?

Disopyramide phosphate has active ingredients of disopyramide phosphate. It is often used in heart palpitations. eHealthMe is studying from 485 Disopyramide phosphate users. Check the latest studies of Disopyramide phosphate.

What is Ventricular tachycardia?

Ventricular tachycardia (rapid heartbeat that originates in one of the lower chambers (the ventricles) of the heart) is found to be associated with 1,291 drugs and 2,094 conditions by eHealthMe. Check the latest studies of Ventricular tachycardia.

On Jul, 08, 2026

470 people reported to have side effects when taking Disopyramide phosphate.
Among them, 11 people (2.34%) have Ventricular tachycardia.

Could Disopyramide phosphate cause Ventricular tachycardia?

Among these 11 people:

What is the gender of people who have Ventricular tachycardia when taking Disopyramide phosphate? *

female: 80 %
male: 20 %

What is the age of people who have Ventricular tachycardia when taking Disopyramide phosphate? *

What are other drugs people take besides Disopyramide phosphate? *

What are other side effects people have besides Ventricular tachycardia? *

Electrocardiogram Qt Prolonged: 4 people, 36.36%
Hypokalemia (low potassium): 3 people, 27.27%
Cardiac Arrest: 3 people, 27.27%
Extrasystoles: 2 people, 18.18%
Torsade De Pointes (a abnormal heart rate with abnormal beating pattern): 2 people, 18.18%
Arrhythmias (irregular heartbeat): 2 people, 18.18%
Long Qt Syndrome (disorder of the heart's electrical system): 2 people, 18.18%
Hypotension (abnormally low blood pressure): 1 person, 9.09%
Hypoglycemia (low blood sugar): 1 person, 9.09%
Fainting (loss of consciousness and postural tone): 1 person, 9.09%

What are the existing conditions these people have? *

Obstructive Airways Disorder (a progressive disease that makes it hard to breathe): 2 people, 18.18%
Insomnia (sleeplessness): 2 people, 18.18%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 18.18%
Gallstones (stone formation by bile component): 2 people, 18.18%
Endometrial Cancer: 2 people, 18.18%
Cardiac Failure Chronic: 2 people, 18.18%
Bronchiolitis (inflammation of the membranes lining the bronchioles in lungs): 2 people, 18.18%
Type 2 Diabetes: 1 person, 9.09%
Pain: 1 person, 9.09%
Nodal Rhythm (40-50 beats per minute): 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Disopyramide phosphate and have Ventricular tachycardia?

- Check whether Ventricular tachycardia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Disopyramide phosphate:

Disopyramide phosphate (485 reports)

Browse all side effects of Disopyramide phosphate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ventricular tachycardia:

Ventricular tachycardia (1,291 drugs)

Browse all the conditions that are associated with Ventricular tachycardia:

Ventricular tachycardia (2,094 conditions)

Related publications that referenced our studies

Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .
Amit K J Mandal, Umar F Khan, Constantinos G Missouris, "Ventricular tachycardia in a patient with sigmoid volvulus on treatment with donepezil", Clinical Toxicology, 2019 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on disopyramide phosphate (the active ingredients of Disopyramide phosphate) and Disopyramide phosphate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.